Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2018

Hao Dapeng, Liu Jie, Chen Meng, Li JingJing, Wang Li, Li Xiaobo, Zhao Qi, Di Li-Jun

Abstract excerpt

Purpose: Ovarian cancer is one of the first human cancers for which in situ immune response was reported to be important for the clinical outcome. To elucidate the mechanistic relationship between immune repertoire and cancer genotype in ovarian cancer, the development of a well-defined immune score for ovarian cancer is required.Experimental Design: From a collection of 2,203 patient samples of advanced ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystadenocarcinoma, Serous
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genome, Human

Share to Immunity, Innate

Share to Kaplan-Meier Estimate

Share to Ovarian Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 29661778
DOI: 10.1158/1078-0432.CCR-17-3862

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity.PMID 29661778Read ↗

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profilingSemantic proximity Read ↗

Development and validation of an immune gene-set based Prognostic signature in ovarian cancerSemantic proximity Read ↗

Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancerSemantic proximity Read ↗

New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.Semantic proximity Read ↗

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian CancerSemantic proximity Read ↗

Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes.Semantic proximity Read ↗

A Nine-Immune-Related Gene Prognostic Signature for Predicting Outcomes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.Semantic proximity Read ↗

Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.Semantic proximity Read ↗

Analyzing the extracellular matrix-dominated immune landscape of high-grade serous ovarian cancer to determine prognosis and guide therapySemantic proximity Read ↗

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.Semantic proximity Read ↗

Prognostic Risk Model of Immune-Related Genes In Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.